Loading clinical trials...
Loading clinical trials...
This interventional study aims to evaluate the safety and efficacy of oral capsule fecal microbiota transplantation (FMT) for treating hepatic encephalopathy refractory to conventional rifaximin and l...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NCT07199998 · Sexual Transmitted Disease, Vaginosis, Bacterial, and more
NCT05966649 · Preterm Spontaneous Labor With Preterm Delivery, Preterm Birth, and more
NCT06588218 · Obesity and Overweight, Dysbiosis
NCT07191171 · Dysbiosis
NCT06483737 · Overt Hepatic Encephalopathy
Fondazione Policlinico Agostino Gemelli IRCCS
Rome
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions